The 20 Best Dysembryoplastic Neuroepithelial Tumors (DNET) Doctors Near Me in San Francisco, CA

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Weber is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Dysembryoplastic Neuroepithelial Tumors (DNET), Spondylolisthesis, Brain Stem Cancer, Microdiscectomy, and Herniated Disc Surgery. Dr. Weber is board certified in Neurological Surgery. Dr. Weber is currently accepting new patients.

Dr. Philip Theodosopoulos is director of the Skull Base Tumor Program and vice chair of neurological surgery at UCSF. Before joining UCSF, he served as director of skull base surgery at the University of Cincinnati for 10 years. Theodosopoulos cares primarily for patients with skull base lesions, particularly malignancies and acoustic neuromas – noncancerous tumors that grow on nerves near the ear. His expertise includes endoscopic treatment of pituitary adenomas and chordomas as well as minimally invasive approaches to the skull base. Theodosopoulos has been a pioneer in the development of new surgical approaches to the skull base. He served as co-principal investigator for the largest prospective multicenter trial of surgical treatment for acoustic neuromas, and he currently serves on the Acoustic Neuroma Association's medical advisory board. He also has extensive expertise in research on patient outcomes. As a resident at UCSF, he completed the full curriculum for outcomes research and clinical epidemiology, and he continues to be involved in outcomes research at both the local and national levels. Theodosopoulos earned his undergraduate degree at the Massachusetts Institute of Technology and completed medical school at Stanford University. He completed his neurosurgical training at UCSF, followed by a fellowship in cerebrovascular and skull base surgery at the Brigham and Women's Hospital, an affiliate of Harvard Medical School. Theodosopoulos has been on the faculty for more than 50 national and international surgical courses. He serves on the education committee for the Congress of Neurological Surgeons. He serves as residency program director for neurological surgery at UCSF. Dr. Theodosopoulos is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Schwannoma, Acoustic Neuroma, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Balloon Sinuplasty. Dr. Theodosopoulos is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Theodosopoulos is currently accepting new patients.

Nicholas Butowski is a Neurologist practicing medicine in San Francisco, California. Dr. Butowski is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Matthew Macdougall is a Neurologist and a Neurosurgery provider practicing medicine in San Francisco, California. Dr. Macdougall is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Spinal Cord Abscess, Epidural Abscess, Subdural Hematoma, Deep Brain Stimulation, and Awake Craniotomy. Dr. Macdougall is currently accepting new patients.

Arnold Greenberg is a Neurologist practicing medicine in San Francisco, California. Dr. Greenberg is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Pseudobulbar Affect, Benign Paroxysmal Positional Vertigo, Dysembryoplastic Neuroepithelial Tumors (DNET), and Brain Stem Cancer.

Caring, compassionate, and patient centered care. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, and Astrocytoma. Dr. Lee is board certified in Radiology Diagnostic Radiology. Dr. Lee is currently accepting new patients.

Dr. Ronald S. Greenwald's areas of expertise include cervical and lumbar spine and brain surgery in Mountain View and Redwood City. Dr. Greenwald is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). His clinical expertise encompasses Cervical Myelopathy, Cervical Spondylosis, Meningioma, and Sciatica. Dr. Greenwald is board certified in Neurological Surgery. Dr. Greenwald is currently accepting new patients.

Dr. Michael Huang is a neurosurgeon who specializes in brain disorders, including tumors and blood vessel abnormalities. He has extensive training in managing meningiomas, pituitary tumors, acoustic neuromas, aneurysms, vascular malformations, extracranial carotid artery disease, cerebral revascularization and trigeminal neuralgia. In his research, Huang studies traumatic injuries to the neurological system. He looks at neurointensive care and is particularly interested in advanced neurological monitoring for traumatic brain injury and spontaneous subarachnoid hemorrhage, skull base fractures and endocrinological disturbances following trauma. He also is interested in surgical approaches to treating skull base diseases, including the use of endoscopic and other minimally invasive techniques. Huang earned his medical degree at Weill Cornell Medicine and completed a residency in neurosurgery at MedStar Georgetown University Hospital. He completed a skull base and cerebrovascular fellowship at the University of South Florida. Dr. Huang is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Subdural Hematoma, Subdural Hematoma, Delirium, Apoplexy, and Gastrostomy. Dr. Huang is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Huang is currently accepting new patients.

Isaac Yang is a Neurosurgery provider practicing medicine in San Francisco, California. Dr. Yang is rated as a Distinguished provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Meningioma, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, Awake Craniotomy, and Gamma Knife Radiosurgery.

Akanksha Sharma is a Neurologist practicing medicine in San Francisco, California. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Metastatic Brain Tumor, Brain Tumor, Astrocytoma, and Glioblastoma. Dr. Sharma is board certified in Neurology - Board Certified. Dr. Sharma is currently accepting new patients.

Lewis Leng is a Neurologist and a Neurosurgery provider practicing medicine in San Francisco, California. Dr. Leng is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Arterial Calcification of Infancy, PHACE Syndrome, Hydrocephalus, Balloon Sinuplasty, and Awake Craniotomy. Dr. Leng is board certified in Neurological Surgery.

Dr. Manish Aghi is a neurosurgeon specializing in brain tumors at UCSF Medical Center. He cares for adult patients with a wide range of conditions, including astrocytomas and anaplastic astrocytomas, oligodendrogliomas, glioblastomas, meningiomas and pituitary adenomas. As principal investigator at the UCSF Brain Tumor Research Center, his interests include glioblastoma angiogenesis, mechanisms of glioblastoma resistance to anti-angiogenic therapy and experimental glioblastoma therapies such as cancer-killing viruses. Aghi earned his medical degree and a doctoral degree in neurosciences from Harvard Medical School. He completed a residency in neurosurgery at Massachusetts General Hospital. He is a member of the Society for Neuro-Oncology, American Association of Neurological Surgeons, Congress of Neurological Surgeons and Pituitary Network Association. Among his honors are the Preuss and Mahaley awards from the American Association of Neurological Surgeons, and the Ronald L. Bittner Award, Synthes Skull Base Award and Integra Foundation Award from the Congress of Neurological Surgeons. Dr. Aghi is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Hypothalamic Tumor, Prolactinoma, Balloon Sinuplasty, and Awake Craniotomy. Dr. Aghi is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Aghi is currently accepting new patients.

Dr. Shawn Hervey-Jumper is a neurosurgeon specializing in the treatment of patients with brain tumors, including low- and high-grade gliomas, meningiomas, brain metastases and neurocutaneous syndromes. Hervey-Jumper's research investigates how brain tumors violate important areas of the brain that affect how we move, speak and think. He also explores strategies to promote brain recovery and repair. In addition, he researches ways to map the human brain during surgery with the goal of limiting injury to key functional areas. Hervey-Jumper received his medical degree from the Ohio State University College of Medicine. He completed both a residency in neurosurgery and a fellowship in neuro-oncology at the University of Michigan. He then completed a clinical fellowship in neuro-oncology at UCSF. Hervey-Jumper is a member of the Society for Neuro-Oncology, American Association for Cancer Research, North American Skull Base Society, American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS). He is also a member of the joint section on tumors for the latter organizations. He is an associate professor in residence of neurological surgery at UCSF. Dr. Hervey is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Hervey is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Hervey is currently accepting new patients.

Nancy Bush is a Neurologist practicing medicine in San Francisco, California. Dr. Bush is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Astrocytoma. Dr. Bush is board certified in American Board Of Psychiatry And Neurology., Neurology. Dr. Bush is currently accepting new patients.

Dr. Susan Chang is a neuro-oncologist who specializes in treating adults with brain tumors. She is director of neuro-oncology at the Brain Tumor Center. Chang also performs studies of experimental brain tumor treatments and evaluates the use of imaging techniques as treatment tools. Specifically, she was one of the recipients of a SPORE grant for evaluating the role of magnetic resonance spectroscopy in diagnosing tumors and evaluating therapeutic interventions. SPORE, which stands for Specialized Programs of Research Excellence, is a program of the National Cancer Institute. She is a principal investigator of a research project funded by the National Institutes of Health that focuses on optimizing the management of patients with glioblastoma, an aggressive brain cancer that's difficult to treat. In addition, Chang is medical director of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, developed to address the needs of family members and others who care for patients with brain tumors. Chang received her medical degree from the University of British Columbia and completed a residency in internal medicine at Plains Health Centre and Toronto General Hospital. She completed a fellowship in medical oncology at Princess Margaret Hospital in Toronto as well as a fellowship in neuro-oncology at UCSF, where she later joined the faculty. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Subependymoma, Dysembryoplastic Neuroepithelial Tumors (DNET), Brain Stem Cancer, and Posterior Fossa Tumor. Dr. Chang is currently accepting new patients.

Anthony Barkovich is a Radiologist practicing medicine in San Francisco, California. Dr. Barkovich is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Cerebellar Hypoplasia, Polymicrogyria, Cortical Dysplasia, and Meningioma.

Dimitrios Giannakidis is a Neurologist practicing medicine in San Francisco, California. Dr. Giannakidis is rated as an Advanced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Stroke, Vertebral Artery Dissection, Gallbladder Removal, and Endoscopy.

Dr. Steve Braunstein is a radiation oncologist who cares for both adult and pediatric patients. He specializes in treating brain and spinal tumors, sarcomas, lymphoma and pediatric cancers. He also provides palliative radiotherapy to reduce symptoms in patients with advanced cancer. His expertise encompasses a number of technologies that use radiation as therapy, with a special focus on intraoperative radiotherapy and radiosurgery – using targeted high-dose radiation to destroy tumors, either as an alternative to surgical procedures or in combination with them. Braunstein's primary areas of research include improving radiation planning and treatment through the use of both gene marker analysis and advanced imaging technologies. He also studies how to improve the coordination, timing and delivery of health care that involves a variety of disciplines, including symptom management and cancer specialties. After earning his medical degree as well as a doctorate in biomedical sciences at New York University School of Medicine, Braunstein completed a residency in radiation oncology at UCSF. Braunstein is program director of UCSF's residency program and has a special interest in educating residents and medical students. He received a UCSF Medical Center Exceptional Physician Award in 2013. Braunstein serves as an editor for the International Journal of Radiation Oncology, Biology and Physics. He belongs to the American Society for Radiation Oncology, American Society of Clinical Oncology, Children's Oncology Group, Radiological Society of North America, North American Skull Base Society, International Gamma Knife Research Foundation and International Stereotactic Radiosurgery Society. He is active on committees within the National Cancer Institute, Children's Oncology Group and NRG Oncology. Dr. Braunstein is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Meningioma, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Osteotomy. Dr. Braunstein is board certified in American Board Of Radiology, Radiation Oncology. Dr. Braunstein is currently accepting new patients.

Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Vitrectomy, and Bone Marrow Aspiration. Dr. Rubenstein is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Rubenstein is currently accepting new patients.

Dr. Jennie Taylor specializes in caring for adults with primary brain tumors, or tumors that start in the brain. As a member of the UCSF Brain Tumor Research Center, she is involved in developing new treatment strategies, innovative imaging techniques and comprehensive tumor analyses, with the goal of improving outcomes for patients with brain tumors. Taylor's research interests include analyzing molecular and imaging markers of resistance to current standard treatments for brain tumors. She also focuses on improving quality of life for patients with primary brain tumors as well as for their caregivers. Taylor earned her medical degree from the University of Kentucky College of Medicine. She completed an internship in medicine and a residency in neurology at the University of Virginia. She completed a fellowship in neuro-oncology at Massachusetts General Hospital and the Dana-Farber Cancer Institute while earning a master's degree in public health from the Harvard T.H. Chan School of Public Health. Taylor is a member of the American Academy of Neurology, Society for Neuro-Oncology and American Society of Clinical Oncology. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Dysembryoplastic Neuroepithelial Tumors (DNET). She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Taylor is board certified in American Board Of Psychiatry/Neurology-Neurology, Neurology. Dr. Taylor is currently accepting new patients.